No headlines found.
MESA LABS ANNOUNCES AMENDMENT TO CREDIT FACILITY AND REPURCHASE OF SENIOR CONVERTIBLE NOTES
Globe Newswire (Mon, 8-Apr 8:00 AM ET)
MESA LABS DECLARES QUARTERLY DIVIDEND
Globe Newswire (Thu, 4-Apr 6:24 PM ET)
Globe Newswire (Mon, 1-Apr 10:27 AM ET)
Mesa Labs Releases Second Annual Responsible Business Program Brochure
Globe Newswire (Fri, 15-Mar 7:00 AM ET)
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, cleaning, and chemical indicators. It also provides testing and laboratory services, mainly to the dental industry; Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions; Calibration Solutions division develops, manufactures, and sells quality control and calibration products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters for health and safety purposes; and Clinical Genomics. Its geographical segments include United States and Foreign.
Mesa Laboratories trades on the NASDAQ stock market under the symbol MLAB.
As of April 19, 2024, MLAB stock price climbed to $100.74 with 25,901 million shares trading.
MLAB has a beta of 0.66, meaning it tends to be less sensitive to market movements. MLAB has a correlation of 0.04 to the broad based SPY ETF.
MLAB has a market cap of $542.41 million. This is considered a Small Cap stock.
Last quarter Mesa Laboratories reported $53 million in Revenue and $2.02 earnings per share. This fell short of revenue expectation by $-1 million and exceeded earnings estimates by $1.83.
In the last 3 years, MLAB stock traded as high as $333.42 and as low as $82.86.
The top ETF exchange traded funds that MLAB belongs to (by Net Assets): IJR, VTI, IWM, VXF, IJS.
MLAB stock has underperformed the market in the last year with a return of -39.5%, while SPY returned +21.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in MLAB shares. However, MLAB has outperformed the market in the last 3 month and 2 week periods, returning +10.6% and -0.2%, while SPY returned +3.0% and -4.5%, respectively. This indicates MLAB has been having a stronger performance recently.
MLAB support price is $95.77 and resistance is $103.47 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MLAB stock will trade within this expected range on the day.